Target Name: ZNF70
NCBI ID: G7621
Review Report on ZNF70 Target / Biomarker Content of Review Report on ZNF70 Target / Biomarker
ZNF70
Other Name(s): zinc finger protein 70 | ZNF70_HUMAN | Zinc finger protein 70 | Cos17 | Zinc finger protein N27C7-1 | zinc finger protein N27C7-1

Understanding ZNF70: Structure, Function, Drug Targets and Potential Treatments

ZNF70, also known as zinc finger protein 70, is a protein that is expressed in nearly all eukaryotic cells. Its function has been extensively studied in cell biology and plays an important role in many biological processes. In recent years, with the development of gene editing technology, researchers have learned more and more about ZNF70. In this article, we will explore the structure, function, drug targets, and potential treatments of ZNF70.

1. Structure

ZNF70 is a zinc finger transcription factor, and its name comes from its zinc finger structure. The zinc finger of ZNF70 is formed by two cysteine 鈥嬧?媟esidues connected by hydrogen bonds. This structure allows ZNF70 to bind zinc ions to DNA, thereby regulating gene expression.

2. Function

ZNF70 plays multiple functions in cell biology. It plays a key role in cell proliferation, differentiation and apoptosis. During cell proliferation, ZNF70 can bind to specific sequences on DNA to regulate gene expression. During the differentiation process, ZNF70 can participate in regulating cell fate, including cell differentiation, orientation and morphology maintenance. During the process of apoptosis, ZNF70 can regulate intracellular signaling and thus participate in apoptosis.

In addition, ZNF70 is also involved in many important biological processes, including cell cycle regulation, intracellular trafficking, cell adhesion and cell migration. It also interacts with many important biological processes, including cell signaling, cell cycle, apoptosis and cell differentiation.

3. Drug Targets

ZNF70 is a very attractive drug target because it has been found to be abnormally expressed in many diseases. ZNF70 has been found to be highly expressed in many cancers, including lung cancer, breast cancer, oral cancer and lymphoma. In addition, ZNF70 is also closely related to a variety of autoimmune diseases and neurological diseases.

4. Treatment methods

Currently, treatments for ZNF70 mainly include drug inhibition and gene editing.

1. Drug inhibition

Drug inhibition strategies for ZNF70 mainly include inhibitor design, small molecule screening and clinical trials. Currently, some research teams are developing drugs that inhibit the function of ZNF70 in order to combat lung cancer, breast cancer and other diseases. For example, a drug targeting ZNF70 is in clinical trials and is designed to inhibit the function of ZNF70 to treat lung cancer.

2. Gene editing

Gene editing technology is another approach to treat ZNF70. Researchers have developed gene editing technologies, such as the CRISPR/Cas9 system, that can be used to precisely edit the ZNF70 gene. Through gene editing, the function of ZNF70 can be precisely regulated and its therapeutic effect on diseases improved.

In summary, ZNF70 is a very attractive drug target that can be used to treat many diseases. Future research will continue to conduct in-depth studies on the structure, function, drug targets and potential treatments of ZNF70, with a view to bringing more help to human health.

Protein Name: Zinc Finger Protein 70

Functions: May be involved in transcriptional regulation

The "ZNF70 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF70 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823